Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00509704
What this trial is testing

Influence of Sutent on Tumor Vascularization and Necrosis in Patients With Renal Cell Carcinoma

Who this might be right for
Renal Cell Cancer
Radboud University Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT03179904
What this trial is testing

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaHER2-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic 17
Not applicableUnknownNCT00945984
What this trial is testing

Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma

Who this might be right for
Localized Renal Cell Carcinoma
Seoul National University Hospital 36
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Not applicableStudy completedNCT01687738
What this trial is testing

Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention

Who this might be right for
Non-small Cell Lung Cancer
University of North Carolina, Chapel Hill 238
Testing effectiveness (Phase 2)Active Not RecruitingNCT04340258
What this trial is testing

Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Who this might be right for
HNSCC
University of Cincinnati 50
Testing effectiveness (Phase 2)Ended earlyNCT04108858
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8HER2-Positive Breast CarcinomaMetastatic Breast Carcinoma
National Cancer Institute (NCI) 2
Early research (Phase 1)WithdrawnNCT06357858
What this trial is testing

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the Head and NeckMetastatic Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Case Comprehensive Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT06743555
What this trial is testing

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Who this might be right for
Non-Small Cell Lung CancerImmunotherapyNeoadjuvant Therapy+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 14
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Not applicableEnded earlyNCT06419478
What this trial is testing

Postoperative Symptoms in Chinese Liver Cancer Patients: Network Analysis

Who this might be right for
Patients With Primary Liver Cancer (PLC) Undergoing Curative Surgical ProceduresImportance of Identifying Core Symptoms for Improving Symptom Management in PLC PatientsApplication of Network Analysis as a Crucial Component of Cancer Care
Mengmeng Yuan 249
Not applicableLooking for participantsNCT06835426
What this trial is testing

High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins

Who this might be right for
Breast CarcinomaProstate Cancer SurgeryThyroid Cancer+10 more
Algemeen Ziekenhuis Maria Middelares 150
Testing effectiveness (Phase 2)Study completedNCT01037998
What this trial is testing

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer
Taipei Veterans General Hospital, Taiwan 115
Testing effectiveness (Phase 2)Study completedNCT00068393
What this trial is testing

Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell CarcinomaRenal Cell Carcinoma With Sarcomatoid Features
Eastern Cooperative Oncology Group 39
Not applicableStudy completedNCT06607393
What this trial is testing

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

Who this might be right for
Metastatic Nonsmall Cell Lung Cancer
Aetion, Inc. 851
Early research (Phase 1)UnknownNCT06225921
What this trial is testing

Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas

Who this might be right for
Esophageal Squamous Cell Carcinoma
West China Hospital 6
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05668884
What this trial is testing

GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Fudan University 93
Very early researchEnded earlyNCT02827838
What this trial is testing

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Who this might be right for
Human Papillomavirus InfectionStage I Oral Cavity Squamous Cell CarcinomaStage I Oropharyngeal Squamous Cell Carcinoma+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00230126
What this trial is testing

OSI-774 in African American Patients With Advanced and Previously Treated Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ohio State University Comprehensive Cancer Center 57
Next Page